Open Access
E3S Web Conf.
Volume 328, 2021
International Conference on Science and Technology (ICST 2021)
Article Number 01001
Number of page(s) 4
Section Chemical Engineering, Physical Characteristics, Water Treatment
Published online 06 December 2021
  1. C. H. Ansel, Pengantar Bentuk Sediaan Farmasi Terjemahan Farida Ibrahim Edisi IV. Jakarta: Universitas Indonesia Press, 1989. [Google Scholar]
  2. Zubaedah, “Perbandingan Mutu Fisik dan Profil Disolusi Tablet Ibuprofen Merk Dagang dan Generik,” Universitas Muhammadiyah Surakarta, 2009. [Google Scholar]
  3. G. Tiwari et al., “Drug delivery systems: An updated review,” Int. J. Pharm. Investig., vol. 2, no. 1, p. 2, (2012), doi: 10.4103/2230973x.96920. [CrossRef] [PubMed] [Google Scholar]
  4. K. H. K. Brahma N. Singh, “Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention,” J. Control Release, vol. 63, no. 3, pp. 235–259, (2000), [Online]. Available: [CrossRef] [Google Scholar]
  5. C. G. Wilson and K. Kelly, “Gastrointestinal transit and drug absorption,” Pharm. Dissolution Test., vol. 25, no. February, pp. 97–125, (2005), doi: 10.3109/9781420077346-4. [Google Scholar]
  6. N. S. . Gopinath, Harish, Rudru S., Chakravarthi V., Asma S., “Formulation And Evaluation Of Ofloxacin Floating Tablets By Using Hydroxyl Propyl Methyl Cellulose As Polymer,” J. Chem. Pharm. Sci., vol. 5, pp. 144–149, (2012). [Google Scholar]
  7. B. R. Streubel A, Siepmann J, “Multiple unit gastroretentive drug delivery systems: a new preparation method for low density microparticles. J Microencapsul.,” J. Microencapsul, vol. 20, no. 3, pp. 329–347, (2003), doi: 10.1080/0265204021000058384. [CrossRef] [PubMed] [Google Scholar]
  8. A. S. Surana and R. K. Kotecha, “An overview on various approaches to oral controlled drug delivery system via gastroretention,” Int. J. Pharm. Sci. Rev. Res., vol. 2, no. 2, pp. 68–72, (2010). [Google Scholar]
  9. R. Khan, “Gastroretentive drug delivery system -A review,” Int. J. Pharma Bio Sci., vol. 4, no. 2, pp. 80–89, (2013), doi: 10.21276/apjhs.2014.1.2.9. [Google Scholar]
  10. M. Cazzola et al., “Efficacy and safety profile of xanthines in COPD: A network metaanalysis,” Eur. Respir. Rev., vol. 27, no. 148, pp. 1–12, (2018), doi: 10.1183/16000617.00102018. [Google Scholar]
  11. A. M. Bayomi, M.A., Al-Suwayeh, S.A., El-Helw, “Excipient-Excipient Interaction in the Design of Sustained-Release Theophylline Tablets: In Vitro and In Vivo Evaluation,” Drug Dev. Ind. Pharmac, vol. 27, no. 6, pp. 499–506, (2001). [CrossRef] [PubMed] [Google Scholar]
  12. M. Sowjanya, S. Debnath, P. Lavanya, R. Thejovathi, and M. N. Babu, “Polymers used in the Designing of Controlled Drug Delivery System,” Res. J. Pharm. Technol., vol. 10, no. 3, p. 903, (2017), doi: 10.5958/0974360x.2017.00168.8. [CrossRef] [Google Scholar]
  13. S. Goyal, G. Agarwal, S. Agarwal, and P. K. Karar, “Oral Sustained Release Tablets: An Overview with a special emphasis on Matrix Tablet,” Am. J. Adv. Drug Deliv., vol. 05, no. 02, (2017), doi: 10.21767/2321-547x.1000013. [Google Scholar]
  14. G. T. Reilly, T. M., Tiwari, S. B. dan Krayz, “Formulating Hydrophilic Matrix System,” Drug Deliv. Technol., vol. 7, no. 1, pp. 23–27, (2009). [Google Scholar]
  15. P. Franco and I. De Marco, “The use of poly(Nvinyl pyrrolidone) in the delivery of drugs: A review,” Polymers (Basel)., vol. 12, no. 5, pp. 18–21, (2020), doi: 10.3390/POLYM12051114. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.